Hidden biases in an observational study of bevacizumab beyond progression.
Kopetz
Scott
S
Abbruzzese
James L
JL
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068258:Bevacizumab; D015982:Bias; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000453:epidemiology*; D018450:Disease Progression; D015340:Epidemiologic Research Design; D010818:Practice Patterns, Physicians'
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068258:Bevacizumab